Tropomyosins in human diseases: Ulcerative colitis

Advances in Experimental Medicine and Biology

Volumn 644, Issue , 2008, Pages 158-167

  Das, Kiron M ^a   Bajpai, Manisha ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOKINE; TPM3 PROTEIN, HUMAN; TROPOMYOSIN;

ANIMAL; AUTOIMMUNITY; BIOLOGICAL MODEL; CHEMISTRY; COLON; CYTOLOGY; CYTOSKELETON; EPITHELIUM CELL; FAMILY HEALTH; HUMAN; IMMUNE SYSTEM; INFLAMMATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; REVIEW; ULCERATIVE COLITIS;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; COLITIS, ULCERATIVE; COLON; CYTOKINES; CYTOSKELETON; EPITHELIAL CELLS; FAMILY HEALTH; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MODELS, BIOLOGICAL; TROPOMYOSIN;

EID: 60849121759     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-85766-4_13     Document Type: Article

References (55)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115:182-205. (Pubitemid 28307304)
2. MacDonald TT, Monteleone G. Immunity, inflammation and allergy in the gut. Science 2005; 307:1920-1925.
3. Fuss IJ, Neurath M, Boirivant M et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-1270. (Pubitemid 126449643)
4. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterology 2004; 126:1620-1633. (Pubitemid 38649878)
5. Ahmad T, Marshall S, Jewell D. Genotype-based phenotyping heralds a new taxonomy for inflammatory bowel disease. Curr Opin Gastroenterol 2003; 19:327-335. (Pubitemid 36819785)
6. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterolog y 2003; 124:521-536. (Pubitemid 36169267)
7. Satsangi J, Morecroft J, Shah NB et al. Genetics of inflammatory bowel disease: scientific and clinical implications. Best Pract Res Clin Gastroenterol 2003; 17:3-18.
8. Schwab M, Schaeffeler E, Marx C et al. Association between the C3435T MDRI gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 2003; 124:26-33. (Pubitemid 36055335)
9. Brandtzaeg P. Autoimmunity and ulcerative colitis: Can two enigmas make sense together? Gastroenterology 1995; 109:3007-312.
10. Broberger O, Perlmann P. Autoantibodies in human ulcerative colitis. J Exp Med 1959; 110:657-674.
11. Fiocchi C, Roche JK, Michener WM. High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann Intern Med 1989; 110:786-794. (Pubitemid 19128996)
12. Yonamine Y, Watanabe M, Kinjo F et al. Generation of MHC class 1-restricted cytotoxic T-cell lines and clones against colonic epithelial cells from ulcerative colitis. J Clin Immunol 1999; 110:786-794.
13. Dasgupta A, Ramaswamy K, Giraldo J et al. Colon epithelial cellular protein induces oral tolerance in the experimental model of colitis by trinitrobenzene sulfonic acid. J Lab and Clin 2001; 138:257-269. (Pubitemid 32901099)
14. Hollander GA, Simpson SJ, Mozoguchi E et al. Severe colitis in mice with aberrant thymic selection. Immunity 1995; 3:27-38.
15. Inoue N, Watanabe M, Sato T et al. Restricted VH gene usage in lamina propria B-cells producing anticolon antibody from patients with ulcerative colitis. Gastroenterology 2001; 121:15-23. (Pubitemid 32591511)
16. Das KM, Dubin R, Nagai T. Isolation and characterization of colonic tissue bound antibodies from patients with idiopathic ulcerative colitis. Proc Natl Acad Sci (USA) 1978; 75:4528-4532. (Pubitemid 9028390)
17. Takahashi F, Das KM. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound IgG from idiopathic ulcerative colitis. J Clin Invest 1985; 76:311-318. (Pubitemid 15243458)
18. Halstensen TS, Mollnes TE, Barred P et al. Surface epithelium-related activation of complement differs in Crohn's disease and ulcerative colitis. Gut 1992; 33:902-908.
19. Halstensen TS, Mollnes TE, Garred P et al. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 1990; 98:1264-1271. (Pubitemid 20143112)
20. Halstensen TS, Das KM, Brandtzaeg P. Epithelial deposits of immunoglobulin G1 and activated complement colocalize with the Mr 40K colonic autoantigen in ulcerative colitis. Gut 1993; 34:650-657. (Pubitemid 23146891)
21. Das KM, Dasgupta A, Mandal A et al. Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis. J Immunol 1993; 150:2487-2493. (Pubitemid 23127495)
22. Lin JJC, Warren KS, Wamboldt DD. Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol 1997; 170:1-38. (Pubitemid 27056583)
23. Biancone L, Mandal A, Yang H et al. Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology 1995; 109:3-12.
24. Geng X, Biancone L, Dai HH et al. Tropomyosin isoform in intestinal mucosa: production of autoantibodies to tropomyosin isoform in ulcerative colitis. Gastroenterology 1998; 114:912-922. (Pubitemid 28217556)
25. Onuma EK, Amenta PS, Ramaswamy K et al. Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B-cell response against human tropomyosin isoform 5. Clin Exp Immunol 2000; 121:466-471.
26. Kett K, Tognum TO, Brandtzaeg P. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology 1987; 93:919-924. (Pubitemid 18000632)
27. Taniguchi M, Geng X, Glazier KD et al. Cellular immune response against tropomyosin isoform 5 in ulcerative colitis. Clin Immunol 2001; 101:1-7.
28. Sakamaki S, Takayanagi N, Yoshizaki N et al. Autoantibodies against the specific epitope of human tropomyosin(s) detected by patients with ulcerative colitis show antibody dependent cell-mediated cytotoxicity against HLA-DPw9 transfected L-cell. Gut 2000; 47:236-241. (Pubitemid 30489767)
29. Mizoguchi A, Mizoguchi E, Chiba C et al. Cytoskeletal imbalance and autoantibody production in T-cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 1996; 183:847-856. (Pubitemid 26113957)
30. Mizoguchi A, Mozoguchi E, Chiba C et al. Role of the appendix in the development of inflammatory bowel disease in TCR alpha mutant mice. J Exp Med 1996; 184:707-715. (Pubitemid 26324124)
31. Dohlman JG, Lupas A, Carson M. Long charge-rich α -helices in systemic autoantigens. Biochem Biophys Res Immunol 2001; 195:686-696.
32. Mor F, Weinberger A, Cohen IR. Identification of alpha-tropomyosin as a target self-antigen in Behcet's syndrome. Eur J Immunol 2002; 32:356-365. (Pubitemid 34173327)
33. Fenderson PG, Fischetti VA, Cunningham MW. Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol 1989; 142:2475-2481. (Pubitemid 19098264)
34. Biancone L, Monteleone G, Marasco R et al. Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives. Clin Exp Immunol 1998; 113:198-205. (Pubitemid 28352837)
35. Das KM, Sakamaki S, Vecchi M et al. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen using the monoclonal antibody. J Immunol 1987; 139:77-84. (Pubitemid 17091764)
36. Kesari KV, Yoshizaki N, Geng X et al. Externalization of tropomyosin isoform 5 in colon epithelial cells. Clin Exp Immunol 1999; 118:219-227. (Pubitemid 29519251)
37. Mirza ZK, Sastri B, Lin JJ-C et al. Autoimmunity against human tropomyosin isoforms (hTms) in ulcerative colitis: localization of specific hTms in the intestine and extraintestinal organs. Inflamm Bowel Dis 2006; 12:1036-1043. (Pubitemid 44665473)
38. Das KM, Squillante L, Robertson F. An increased expression of the Mr 40,000 colonic epithelial protein in DLD-1 colon cancer cells in response to gamma interferon (γ -IFN) and tumor necrosis factor (TNF). Gastroenterology 1989; 96:A111.
39. Geng X, Liu J, Lin JJ-C et al. Gamma interferon increases surface expression and externalization of human tropomyosin isoform 5 (hTm5) in colon epithelial cells. Gastroenterology 2003; 124:A157.
40. Tatar E, Cohen HD, Geng X et al. Human tropomyosin isoform 5 (hTm5) expression is increased in the colonic mucosa from patients with active ulcerative colitis. Gastroenterology 2002; 122:A531.
41. Yantiss RK, Das KM, Farraye F et al. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens help distinguish ulcerative colitis from Crohn's disease and from other forms of colitis. Am J Surg Pathol, In Press.
42. Das KM, Vecchi M, Sakamaki S. A shared and unique epitope(s) on human colon, skin and biliary epithelium detected by a monoclonal antibody. Gastroenterology 1990; 98:464-469. (Pubitemid 20037931)
43. Bhagat S, Das KM. A shared and unique peptide in human colon, eye and joint detected by a novel monoclonal antibody. Gastroenterology 1994; 107:103-108. (Pubitemid 24195351)
44. Das KM. Relationships of extracolonic involvement in inflammatory bowel disease: New insights into autoimmune pathogenesis. Dig Dis Sci 1999; 44:1-13. (Pubitemid 29053071)
45. Karrar A, Broome U, Sodergren T et al. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 2007; 132:1504-1514. (Pubitemid 46627575)
46. Adams DH, Eksteen B. Aberrant homing of mucosal T-cells and extraintestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 2006; 6:244-251. (Pubitemid 43290993)
47. Mandal A, Dasgupta A, Jeffers L et al. Autoantibodies in sclerosing cholangitis against a shared epitope in biliary and colon epithelium. Gastroenterology 1994; 106:185-192. (Pubitemid 24011880)
48. Monsen U, Sorstad J, Hellers G et al. Extracolonic diagnoses in ulcerative colitis: An epidemiological study. Am J Gastroenterol 1990; 85:711-716. (Pubitemid 20185180)
49. Botros N, Pickover L, Das KM. Image of the month. Gastroenterology 2000; 118:654. (Pubitemid 30171613)
50. Ebert EC, Geng X, Lin J et al. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis. Cell Immunol 2006; 244:43-49. (Pubitemid 46659715)
51. Elson CJ, Barker RN, Thompson SJ et al. Immunologically ignorant autoreactive T-cells, epitope spreading and repertoire limitation. Immunol Today 1995; 16:71-76.
52. Biancone L, Palmieri G, Lombardi A et al. Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis. Am J Gastroenterol 2003; 98:2719-2726. (Pubitemid 38020114)
53. Luo Y, Frey EA, Pfuztzner RA et al. Crystal structure of enteropathogenetic Escherichia Coli. Intimin-receptor complex. Nature 2000; 405:1077-1077.
54. Vallance BA, Finlay BB. Exploitation of host cells by enteropathogenic Escherichia Coli. Proc Natl Acad Sci USA 2000; 97:8799-8806. (Pubitemid 30626629)
55. Propato A, Cutrona G, Francavilla V et al. Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross priming. Nat Med 2001; 7:807-813. (Pubitemid 32691635)